Binding of K(ATP) channel modulators in rat cardiac membranes

British Journal of Pharmacology

Volumn 123, Issue 7, 1998, Pages 1395-1402

  Löffler Walz, Cornelia ^a   Quast, Ulrich ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

3H P1075; Glibenclamide; K(ATP) channel opener binding; Rat heart membranes; Sulphonylurea receptor

Indexed keywords

2 CYANO 1 (1,1 DIMETHYLPROPYL) 3 (3 PYRIDYL)GUANIDINE; 4 [[2 (1 PIPERIDYL)BENZHYDRYL]CARBAMOYLMETHYL]BENZOIC ACID; ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE MAGNESIUM; GLIBENCLAMIDE; GLIBORNURIDE; MINOXIDIL SULFATE; PHLOXINE; POTASSIUM CHANNEL; RECEPTOR; SULFONYLUREA;

ANIMAL CELL; AORTA; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG POTENCY; HEART MUSCLE CELL; HEART MUSCLE FIBER MEMBRANE; MALE; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; TEMPERATURE; VASCULAR SMOOTH MUSCLE;

ANIMALS; BINDING SITES; CELL MEMBRANE; GUANIDINES; KINETICS; MALE; MYOCARDIUM; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; VASODILATOR AGENTS;

EID: 0031916167     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701756     Document Type: Article

References (50)

1. AGUILAR-BRYAN, L., NICHOLS, C.G., WECHSLER, S.W., CLEMENT, J.P., BOYD, A.E., GONZALES, G., HERRERA-SOSA, H., NGUY, K., BRYAN, J. & NELSON, D.A. (1995). Cloning of the β cell high-affinity sulfonylurea receptor: A regulator of insulin secretion. Science, 268, 423-426.
2. + channel Kir6.1 expressed in human embryonic kidney cells. J. Physiol., 494, 709-714.
3. +-channels. Cell Signal, 2, 197-214.
4. + channels suggest multiple targets for inhibitory drug molecules. J. Membr. Biol., 142, 309-322.
5. BEVINGTON, P.R. (1969). Data Reduction and Error Analysis for the Physical Sciences. pp. 55-65 and 92-118. New York: McGraw-Hill.
6. + channel openers in rat aorta. J. Biol. Chem., 267, 11689-11692.
7. ATP channels. Diabetes, 45, 1439-1445.
8. ATP channel subunits. Neuron, 18, 827-838.
9. DAVIES, N.W., STANDEN, N.B. & STANFIELD, P.R. (1991). ATP-dependent potassium channels of muscle cells: their properties, regulation, and possible functions. J. Bioenerg. Biomembr., 23, 509-535.
10. DAWSON, R.M.C., ELLIOTT, D.C., ELLIOTT, W. & JONES, K.M. (1986). Stability constants of metal complexes. In Data for Biochemical Research. Third edition. pp. 399-415. Oxford, Clarendon Press.
11. + channels by fluorescein derivatives. J. Biol. Chem., 267, 4557-4563.
12. 3H P1075 to brain, heart and skeletal muscle membranes. FASEB J., 10, A138.
13. 3H]P1075. FASEB J., 7, A354.
14. DRAPER, N.B. & SMITH, H. (1981). Applied Regression Analysis. pp. 85-96 and 458-517. New York: Wiley.
15. + channels. Annu. Rev. Pharmacol. Toxicol., 33, 597-637.
16. EDWARDS, G. & WESTON, A.H. (1994). Effect of potassium channel modulating drugs on isolated smooth muscle. In Handbook of Experimental Pharmacology, Vol. 111, ed Szekeres, L.J. & Papp, G. pp. 469-531. Heidelberg: Springer.
17. + channels in cardiac muscle by the sulphonylurea drug glibenclamide. J. Pharmacol Exp. Ther., 261, 540-545.
18. ATP channel as a receptor for potassium channel openers. J. Biol. Chem., 271, 8796-8799.
19. GARRINO, M.G. & HENQUIN, J.C. (1988). Highly potent and stereo-selective effects of the benzoic acid derivative AZ-DF 265 on pancreatic β-cells. Br. J. Pharmacol., 93, 61-68.
20. 3H]glyburide, to neuronal and muscle preparations. J. Pharmacol. Exp. Ther., 257, 1162-1171.
21. + channel current in atrial myocytes of guinea pig heart. Jpn. J. Pharmacol., 54, 473-477.
22. KATP: An inward rectifier subunit plus the sulfonylurea receptor. Science, 270, 1166-1170.
23. + channels. Neuron. 16, 1011-1017.
24. + channel. J. Biol. Chem., 271, 24321-24324.
25. JONES, L.R., BESCH, H.R., FLEMING JR., J.W., McCONNAUGHEY, M.M. & WATANABE, A.M. (1979). Separation of vesicles of cardiac sarcolemma from vesicles of cardiac sarcoplasmic reticulum. J. Biol. Chem., 254, 530-539.
26. KRAUSE, E., ENGLERT, H. & GÖGELEIN, H. (1995). Adenosine triphosphate-dependent K currents activated by metabolic inhibition in rat ventricular myocytes differ from those elicited by the channel opener rilmakalim. Pflügers Arch., 429, 625-635.
27. + channel openers and glucose deprivation. J. Physiol., 502, 397-408.
28. LEMOINE, H., MANNHOLD, R. & GRITTNER, D. (1996). Binding studies with potassium channel openers (KCO) in smooth muscle cells of calf coronary artery as compared to rat cardiomyocytes. Naunyn-Schmiedeberg's Arch. Pharmacol., 353 (suppl.), R54.
29. LÖFFLER, C. & QUAST, U. (1997). Pharmacological characterization of the sulphonylurea receptor in rat isolated aorta. Br. J. Pharmacol., 120, 476-480.
30. LOWRY, O.H., ROSEBROUGH, N.J., FARR, A.L. & RANDALL, R.J. (1951). Protein measurement with the folin phenol reagent. J. Biol. Chem., 193, 265-275.
31. + channels, to rat glomerular preparations. Naunyn-Schmiedeberg's Arch. Pharmacol., 354, 452-459.
32. NAG, A.C. (1980). Study of non-muscle cells of the adult mammalian heart: a fine structural analysis and distribution. Cytobios, 28, 41-61.
33. NICHOLS, C.G. & LEDERER, W.J. (1991). Adenosine triphosphate-sensitive potassium channels in the cardiovascular system. Am. J. Physiol., 261, H1675-H1686.
34. + channel from rat liver and beef heart mitochondria. J. Biol. Chem., 267, 26062-26069.
35. QUAST, U. (1992). Potassium channel openers: pharmacological and clinical aspects. Fundam. Clin. Pharmacol., 6, 279-293.
36. 3H]P1075 in rat isolated aorta: relationship to functional effects of openers and blockers. Mol. Pharmacol., 43, 474-481.
37. 3H]flunitrazepam with the benzodiazepine receptor: evidence for a ligand-induced conformation change. Biochem. Pharmacol., 31, 2761-2768.
38. ATP channel openers in the vascular smooth muscle cell line, A10. Br. J. Pharmacol., 122, 1119-1126.
39. SAKURA, H, ÄMMÄLÄ, C., SMITH, P.A., GRIBBLE, F.M. & ASHCROFT, F.M. (1995). Cloning and functional expression of the cDNA encoding a novel ATP-sensitive potassium channel subunit expressed in pancreatic β-cells, brain, heart and skeletal muscle. FEBS Lett., 377, 338-344.
40. SCHWANSTECHER, M., BACHMANN, C., LÔSER, S. & PANTEN, U. (1995). Interaction of fluorescein derivatives with sulfonylurea binding in insulin-secreting cells. Pharmacology, 50, 182-191.
41. STRYER, L. (1988). Biochemistry. 3rd edition, pp. 317 and 935. New York: W.H. Freeman and Company.
42. SZEWCZYK, A., WOJCIK, G., LOBANOV, N.A. & NALECZ, M.J. (1997). The mitochondrial sulfonylurea receptor: identification and characterization. Biochem. Biophys. Res. Commun., 230, 611-615.
43. TALLARIDA, R.J. (1995). Receptor discrimination and control of agonist-antagonist binding. Am. J. Physiol., 269, E379-E391.
44. + channels. J. Pharmacol. Exp. Ther., 268, 818-825.
45. + channels of cardiac myocytes. Mol. Pharmacol., 36, 897-902.
46. TOMLINS, B., HARDING, S.E., KIRBY, M.S., POOLE-WILSON, P.A. & WILLIAMS, A.J. (1986). Contamination of a cardiac sarcolemmal preparation with endothelial plasma membrane. Biochim. Biophys. Acta. 856, 137-143.
47. + channels in the absence of the sulphonylurea receptor. Nature, 387, 179-183.
48. VAN ALSTYNE, E., BURCH, R.M., KNICKELBEIN, R.G., HUNGER-FORD, R.T., GOWER, E.J., WEBB, J.G., POE, S.L. & LINDEN-MAYER, G.E. (1980). Isolation of sealed vesicles highly enriched with sarcolemma markers from canine ventricle. Biochim. Biophys. Acta. 602, 131-134.
49. + channels in guinea-pig ventricular cells. J. Pharmacol. Exp. Ther., 266, 978-984.
50. + channel. J. Physiol., 499, 715-720.